United States

Back to map

Showing 51-60 of 333 grants

Title Institution Researcher Program Duration Total Award Amount
A pilot study assessing the safety of using a monoclonal antibody against CD40 ligand to achieve a calcineurin inhibitor-free immunosuppression regimen in patients with type 1 diabetes mellitus (T1D) and problematic hypoglycemia undergoing islet cell transplantation The University of Chicago Piotr Witkowski Cures 01-February-2025 to 31-January-2027 $1.000.000,00
Advancing T1D Detection and Care Through AI IQVIA, Inc. Nadejda Leavitt Cures 01-February-2025 to 31-January-2026 $345.083,00
Targeting self-RNA sensing as a trigger of inflammation in type 1 diabetes Trustees of the University of Pennsylvania Qin Li Cures 01-April-2025 to 31-March-2026 $199.919,54
Protective Genetic and Pharmacological Interventions to Prevent Cytokine and Autoimmune-based Destruction of β cells. Icahn School of Medicine at Mount Sinai Romina Bevacqua Cures 01-April-2025 to 31-March-2027 $559.996,54
Modulation of beta cell mRNA Translation in Type 1 Diabetes Beckman Research Institute of the City of Hope Farooq Syed Cures 01-September-2024 to 31-March-2027 $444.138,25
Home-based oral glucose tolerance test for type 1 diabetes screening Yale University Alfonso Galderisi Cures 01-April-2025 to 31-March-2027 $347.849,00
Effects of SGLT2 inhibition on early diabetic kidney disease: interrogation of renal energetics by functional imaging and single-cell transcriptomics University of Washington Petter Bjornstad Improving Lives 01-June-2024 to 30-November-2025 $488.511,63
Eye biorepository: A hub for the restoring vision moonshot Regents of the University of Michigan Patrice Fort Improving Lives 01-March-2025 to 28-February-2026 $218.095,83
Role of oxidative post-translational modifications in generating neoepitopes Weill Medical College of Cornell University Laura Santambrogio Cures 01-April-2025 to 31-March-2028 $600.000,00
Program to Achieve FDA Agreement on Design of Confirmatory Trial for Verapamil Kinexum LLC Michael Zemel Cures 01-December-2024 to 30-June-2025 $160.000,00